NurExone Biologic Inc. (TSXV:NRX)
0.620
-0.020 (-3.13%)
At close: Mar 5, 2026
8.77% (1Y)
| Market Cap | 56.27M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.10M |
| Shares Out | 90.75M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,601 |
| Average Volume | 21,072 |
| Open | 0.640 |
| Previous Close | 0.640 |
| Day's Range | 0.620 - 0.640 |
| 52-Week Range | 0.550 - 1.140 |
| Beta | 0.24 |
| RSI | 40.60 |
| Earnings Date | Mar 30, 2026 |